UNITY Biotechnology Lands $116,000,000 Series B Funding

  • Feed Type
  • Date
    10/31/2016
  • Company Name
    UNITY Biotechnology
  • Mailing Address
    1700 Owens Street San Francisco, CA 94158 USA
  • Company Description
    Imagine a future in which you age, but without the diseases your parents got. A future in which it doesn’t hurt to grow old. At UNITY, we design therapeutics that prevent, halt, or reverse diseases of aging. Our medicines are designed to lengthen healthspan, the amount of time you live in good health.
  • Website
    http://www.unitybiotechnology.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $116,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds from this financing will be used to expand ongoing research programs in cellular senescence and advance the first preclinical programs into human trials.
  • M&A Terms
  • Venture Investor
    ARCH Venture Partners
  • Venture Investor
    Investor
  • Venture Investor
    Fidelity Management & Research Company
  • Venture Investor
    Partner Fund Management
  • Venture Investor
    Venrock
  • Venture Investor
    Bezos Expeditions
  • Venture Investor
    WuXi PharmaTech
  • Venture Investor
    Mayo Medical Ventures

Trending on Xconomy